The epidemic of respiratory disease in early 2010 was characterised by coughing and nasal discharge.
The disease spread through the population of 77,000 Icelandic horses within weeks, leading to a self-imposed ban on their export and significant economic cost to the country.
Initially, due to the speed at which the disease had spread, a viral cause was suspected. However, investigations by researchers at the University of Iceland showed that only Streptococcus zooepidemicus was consistently recovered from coughing horses and rare fatal cases of infection. However, this bacterium is also often found in healthy horses.
The AHT and the Wellcome Trust Sanger Institute were brought in to investigate. Dr Simon Harris from the Wellcome Trust Sanger Institute said: "To identify the culprit, we sequenced the DNA from 257 samples of bacteria from diseased animals and people. This showed that one specific strain of S. zooepidemicus, called ST209, was the likely culprit, and we also found this strain in a human case of blood poisoning. This study highlights, for the first time, how DNA sequencing can be used to identify endemic strains of bacteria and distinguish them from the cause of an epidemic infection."
Iceland is free of all major equine infectious diseases thanks to the ban on the importation of horses into the country in 1882. Consequently, Icelandic horses are particularly susceptible to any new bacteria or virus that crosses the border, and so strict biosecurity regulations are in place to help protect them.
Dr. Sigríður Björnsdóttir of the MAST Icelandic Food and Veterinary Authority, used information from owners and veterinary surgeons to build an epidemiological network. This enabled her to identify an equine rehabilitation centre where horses exercised in a water treadmill. The water treadmill is thought to have provided the perfect conditions for transmitting the disease as water was splashed up and ingested. Horses would complete their rehabilitation and return home, whilst incubating the disease, taking the infection with them.
The ST209 strain of S. zooepidemicus found in Iceland has also been recovered from a coughing horse in Sweden and an abdominal abscess in a Finnish horse trainer.
Dr Andrew Waller, Head of Bacteriology at the AHT, said: "There are a couple of theories as to how the strain entered Iceland. These bacteria are able to survive outside a horse for a week or so, which means the import of contaminated equipment or clothing is the most likely route by which ST209 entered Iceland. However, this particular strain could have even infected a human who travelled to Iceland, before spreading the strain back to a horse and triggering the epidemic.
"We are delighted to have helped uncover the likely identity of the cause of this epidemic. Our investigation highlights the ability of S. zooepidemicus strains to cause disease in animals and people. We found evidence that even endemic strains of S. zooepidemicus were likely causing cases of respiratory disease in Icelandic horses, illustrating that this group of bacteria causes more clinical problems in horses than was previously thought. We hope that raising awareness of the cause of this epidemic, and the likely involvement of a water treadmill as a key factor in disease transmission, will encourage veterinarians around the world to improve disease control precautions preventing future epidemics."
In particular, the two companies are focussing on the production of more video content, with Improve filming and sharing high quality clinical demonstrations, and VetSurgeon.org sharing peer-reviewed community-driven content and knowledge.
VetSurgeon.org Publishing Editor Arlo Guthrie said: “This partnership, which brings together the clinical knowledge and infrastructure of the UK’s leading veterinary training provider with the country’s longest-established online veterinary communities, will substantially increase the amount of valuable content we can bring our members.
“Together, we're going to make VetSurgeon.org THE community for authoritative information and opinions."
To ask questions or discuss the new partnership, click here.
Sporimune is the first ciclosporin oral solution to be licensed for use in both cats and dogs.
In cats with allergic dermatitis, ciclosporin has proved to be an effective alternative to prednisolone1 Dechra says it has a long-term safety record for chronic treatment of canine atopic dermatitis and remains one of the most important tools within a multi-modal strategy.
Sporimune is available with two dosing syringes per bottle – one for cats and one for dogs – that are graduated in body weight and ml.
There are three bottle sizes to allow for flexibility in dispensing and broached bottles last six months.
Dechra Brand Manager Claire Morgan said: "We are delighted to be able to introduce this popular and effective treatment for cats.
"Allergic skin disease can be challenging to diagnose and manage effectively for both owners and vets, with around 20 per cent of all small animal consultations involving skin conditions.
"Sporimune is a key component of a multi-modal approach involving guidance on allergen and flare factor avoidance and improving skin and coat hygiene to minimise clinical signs and the effects on quality of life for both animal and owner."
Reference
This was the sixth time that Mr Warwick Seymour-Hamilton had applied for restoration after being removed from the Register in June 1994, the reasons for which related to the condition of his practice premises and his record-keeping following an inspection by the RCVS. His most recent restoration hearing took place in May 2017.
In his application Mr Seymour-Hamilton said that he wanted to be restored to the Register to aid his research into herbal medicines and, during the course of the hearing, he also challenged some of the evidence given to the Committee in the June 1994 hearing. In particular he challenged the assertion that his practice was open when it was inspected by the RCVS as, he submitted that, he had retired three weeks’ prior to the inspection due to ill-health.
Mr Seymour-Hamilton told the Committee that he did not wish to return to clinical practice but wished to restore his membership of the RCVS in order to prescribe his own herbal treatments and to obtain peer review that would allow his treatments to be licensed. Furthermore, he produced, during the hearing, a continuing professional development (CPD) record card in which he had logged 1,438 hours of CPD in 2017.
In considering his application for restoration the Committee dismissed his challenge to the details of his original hearing in June 1994.
Ms Judith Way, Chairing the Committee and speaking on its behalf, said: "The Committee has noted that this issue is ancient. It is not for this Committee to consider it. Moreover the finding of the Committee represents a determination which was not challenged by the applicant until one of the more recent restoration applications. He never appealed it. Nor did he attend at the original hearing. It acknowledges that the premises could well have been closed given their condition, but whether they were or not is not for it [the Committee] to decide. It is quite possible the applicant has persuaded himself of the position. This is not an issue which is a persuasive factor in this application."
Regarding Mr Seymour-Hamilton’s contention that he would use his RCVS registered status to further his research into herbal treatments Ms Way said: "The Committee accepted there were no direct public protection issues which caused it concern, although it did retain some anxiety that the applicant’s commitment to herbal medicine could govern the way in which he would wish to care for an animal. A more rounded veterinary approach, which involved a full evaluation of an animal’s condition, a coherent diagnosis and a subsequent discussion about treatment with the client is called for."
Turning to his CPD she added: "His CPD now has a bias for herbal medicine as does his extensive reading. The Committee was not satisfied that his skills are up-to-date and that he could practise veterinary medicine safely. The Committee was not satisfied that he would approach a sick animal with the full and rounded approach required of a veterinary surgeon. Nor did his confidence in this regard allay the concerns of the Committee. He expressed belief in himself on the basis of his practice which came to an end some 24 years ago."
The Committee did acknowledge that Mr Seymour-Hamilton’s removal from the Register had a considerable impact on him and that, not only is he ashamed of it, but he believes it is frustrating his ability to advance the cause of herbal medicine.
In conclusion, Ms Way said: "Taking all these matters into account, the Committee has concluded that the applicant has not satisfied it on all of the evidence that he is fit to be restored to the Register and so this application is refused."
Students of the five-year degree will spend two years at Aberystwyth University followed by three years’ study at the RVC’s Hawkshead Campus in Hertfordshire. The first cohort will start in 2021.
Professor Stuart Reid, Principal of the RVC said: "We are delighted to be partnering with our colleagues Aberystwyth in providing an offering that will benefit students at both institutions. The RVC’s commitment to the profession in all its manifestations and particularly the rural environment will be bolstered by this important collaboration."
Professor Elizabeth Treasure, Vice-Chancellor of Aberystwyth University said: "Today marks an important and exciting new chapter in the history of Aberystwyth University and Wales. Agriculture and its related industries play such an important part in the Welsh economy and it is incumbent on us as universities to provide the people and the skills that will contribute to ensuring they thrive for years to come. The new School of Veterinary Science adds a vitally important new piece to the jigsaw, one that will build resilience in the rural economy through education and research at a time of great potential change and challenges.
"Our students will enjoy the best of two worlds at universities that offer academic excellence and an enviable reputation for student experience, and I thank everyone who has contributed to finally realising the vision of a school of veterinary science for Wales."
Photo: Left to right, Professor Stuart Reid, Professor Christianne Glossop, Professor Elizabeth Treasure and Professor Tim Woods.
Eurovet Animal Health has launched Marbiflox 10%, a new marbofloxacin preparation for the treatment of respiratory infections in cattle and pigs.
Eurovet says the product can be used flexibly to provide a single dose treatment, with a concentration-dependent effect and a relatively short withdrawal period. Marbiflox can be administered intravenously, subcutaneously or intramuscularly in cattle or intramuscularly in pigs.
The main indications, with reference to good prescribing practice, are for the treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni and acute forms of mastitis induced by marbofloxacin-sensitive Escherichia coli strains, during lactation. In pigs the main indication is in the treatment of MMA (metritis mastitis agalactia syndrome).
Further information about Marbiflox and the complete Eurovet range of products is available from Eurovet Animal Health. www.eurovet-ah.co.uk/.
As part of the programme, BEVA is giving the coaches workshops, discussion forums and online toolkits to develop their mentoring skills. Having been trained by a specialist mentoring professional, the coaches are then paired with recent graduates to give them guidance and support during the foundation years of their careers.
The project, called 'Leg Up', has been driven by BEVA President Renate Weller, and is being trialled over the next 12 months before being rolled out more widely.
Renate said: "All professionals, but especially new graduates need support in navigating their journey through their chosen career.
"With the veterinary industry’s rapidly changing landscape and rising concern around wellbeing, consistent support and guidance have never been more relevant."
Coaching is open to BEVA concessionary members who have graduated within the past three years. They will be able to self-select a preferred coach on a first come, first served basis from the Leg Up section of the BEVA website.
Renated added: "To date access to targeted careers support has most often depended on where you work and who you know. We hope the scheme will encourage and support those entering the profession, giving them the opportunity to discuss their training, development, career progression and self-care with trained professionals who were once in their shoes."
To find out more and to sign up for the Leg Up programme visit https://www.beva.org.uk/Careers/Leg-Up
The company points to research which shows that half of all pets around the world are reported to be overweight1.
That, of course, places extra load on the joints.
The new diet has been formulated to help dogs lose weight whilst still getting optimal levels of nutrients.
To help with weight loss, Hill's says it has added ingredients which change overweight pets’ gene expression and activate the metabolism to burn excess body fat.
The diet also contains omega-3-rich fish oil to support joint mobility, antioxidants and vitamins to reduce inflammation and support the immune system, and glucosamine and chondroitin, the building blocks of joint cartilage.
The diet comes in four sizes, one for small and mini dogs (1.5kg), two for medium (2.5kg, 12kg), and one for large breeds (12kg).
Hillary Noyes, Hill’s Veterinary Affairs Manager, UK & Republic of Ireland, said: "Excessive weight can increase a dog’s chances of developing mobility issues which can have a hugely detrimental effect on the animal’s health and quality of life.
"Our new Science Plan Perfect Weight & Active Mobility is the perfect solution for those who want to help their best friend maintain a healthy weight and support joints at the same time. "
For more information, speak to your local Territory Manager or visit https://www.hillspet.co.uk/dog-food/sp-canine-adult-perfect-weight-and-active-mobility-medium-chicken-dry
The course will be led by Dr Jon Hall, a European Specialist in Small Animal Surgery and Dr Danielle Gunn-Moore, an RCVS-recognised Specialist in Feline Medicine, supported by RVN Ms Claire Dorey-Phillips. It will take place at Improve’s new practical training facility in Sheffield in January 2019.
Improve says the programme will equip delegates with a full understanding of the causes of FLUTD and help them to advise owners with cats suffering from the condition in order to improve long-term outcomes. It will also provide a comprehensive overview of the nursing and medical options to treat feline idiopathic cystitis (FIC) and other causes of FLUTD including infection, calculi and neoplasia. The range of appropriate surgical methods to treat ureteral obstructions will also be covered, along with the post-operative nursing care, to ensure that delegates feel ready to perform a variety of bladder surgeries with confidence.
Juliet Pope MRCVS, Veterinary Operations Manager at Improve International (pictured right), said: "Treating patients with FLUTD is a team effort so we’re offering a special rate for a vet and nurse attending from the same practice though both vets and nurses can still, of course, book independently. The cutting-edge programme will be highly interactive and we aim to send delegates back to their practices with a revitalised approach to these tricky cat cases."
For further information visit www.improveinternational.com or email enquiries@improveinternational.com or call 01793 759159.
The hour-long webinar will be held on Tuesday 18th May from 7.30pm.
Chris is a European and RCVS Recognised Specialist in Equine Dentistry and the founding Director of the Equine Dental Clinic Ltd. Nicole is a European, American and RCVS Recognised Specialist in Equine Dentistry and is a co-director of the Equine Dental Clinic.
Chris and Nicole (pictured right) will discuss key points for examination, diagnostics and treatment, including:
Zoetis Equine Product Manager, Penny McCann said: "Chris Pearce and Nicole du Toit are known worldwide for their consulting, training, educating and CPD, as well as for running the longest established and largest equine veterinary dental specialist practice in Europe.
"We are delighted that they have agreed to share their knowledge with our client practices on 18th May and look forward to welcoming you."
To book your place for the webinar, visit: https://register.gotowebinar.com/register/173596806534344203
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 8034.
The charity says that one of the biggest issues it faces with guinea pigs is multi-animal households where breeding has become out of control.
Dr Jane Tyson, the RSPCA’s rodent expert, said: "We would always advise owners to have their male guinea pigs neutered before introducing them to a female. We also find that they can sometimes be mis-sexed by the seller or previous owner which leads to accidental breeding so it’s also important to make sure that guinea pigs see a vet regularly who would be able to spot if they have been identified incorrectly.
“Many of the guinea pigs that come into our care have come from a multi-animal home where there have been large numbers of guinea pigs living in often cramped, dirty and unsuitable conditions. This also means that they may have experienced very little handling and are wary and fearful of human hands and need their confidence building up in RSPCA care.
“This is why, this Guinea Pig Appreciation Day, we wanted to encourage people to neuter their guinea pigs and help tackle the problem of overbreeding.”
Katie, who works at Milbourn Equine, is now preparing with her horse Templar Justice, or TJ for short, to take part in what is widely acknowledged to be one of the world's most difficult equestrian events.
Last year, she competed at the Burghley Horse Trials and was voted "Amateur Rider of the Year" by Horse and Hound magazine.
Katie says she is determined to build on that success with a strong showing at Badminton: "The Burghley Horse Trials were amazing last year. I was so excited to be there and it went so well. To now be competing at Badminton will be an awesome experience.
"It’s one of only six 'five-star' equestrian events in the world and to compete there really is my dream come true."
Matt Yarnall from Boehringer Ingelheim said: "This is fantastic news for Bovela which offers a truly unique and innovative way of controlling BVD in a herd, something that is now clearly being appreciated by farmers and vets alike."
The company says over 5 million doses of Bovela have now been sold across Europe2 showing how quickly farmers have understood the benefits of a single dose vaccine that provides a full 12 months of live vaccine protection.
Matt added: "Feedback we have from vets and farmers throughout Europe shows two main things. Firstly, for those who haven’t controlled BVD before, there is the realisation of how much better herd health can be and secondly, for those who have previously struggled with multiple primary course vaccines or those that should be boosted every six months, there is relief at Bovela’s easy-to-follow regime."
References
Dechra Veterinary Products has launched an online CPD programme to help the veterinary profession diagnose, manage and treat dogs suffering from Hyperadrenocorticism (Cushing's syndrome).
The new Canine Hyperadrenocorticism CPD module has been designed to help vets by providing them with a comprehensive overview of the condition, which they can study in their own time and at their own pace. According to Dechra, it aims to take the guesswork out of managing this complex condition and to support vets in improving the quality of life of Cushing's syndrome patients.
It is the latest online CPD course to be offered through The Dechra Academy, a resource which offers a range of learning and support content and client materials. Accounting for six hours' CPD, the Cushing's syndrome online module complements a CPD road show on the disease recently completed by Dechra around the UK. Over 350 vets attended the sessions and further meetings are scheduled for later in 2011.
Greg Williams, Veterinary Technical Services Manager, said: "Cushing's syndrome remains a challenge to the profession because the clinical signs can easily be confused with those of other disorders and tests results are not always clear cut. We know from the strong attendance at our road show earlier this year that there is a real hunger in the profession to build stronger understanding of the disease.
"Through The Dechra Academy, we bring together the latest thinking on a range of clinical conditions and provide practical, up to the minute training, tips, tools and case studies to help vets spread best practice across their clinical and nursing staff. We also offer CPD in a range of formats - face to face, online and video - to ensure we can accommodate the needs of even the busiest practice.
"We're delighted to launch this new module on Cushing's syndrome and know that it will prove to be a useful tool for vets in practice."
For further information on The Dechra Academy or Cushing's syndrome CPD, please contact your Territory Manager, ring Dechra on 01939 211200 or visit www.dechra.co.uk/academy.
Dechra Veterinary Products Ltd is part of Dechra Pharmaceuticals PLC ('Dechra') and offers a range of pharmaceutical products and instruments to veterinary practices in the UK. The company specialises in the development and marketing of licensed branded pharmaceuticals and specialist premium pet foods for companion animals in the global veterinary market. Dechra is committed to developing new products and services that support the work of veterinary professionals and enhance the lives of their patients and also to investing in products and added-value services that deliver its promise to support veterinary professionals and pet owners.
Genitrix has extended its Dentagen dental care range with the addition of Dentagen Aqua, a water additive treatment to control plaque and prevent bad breath in cats and dogs.
Genitrix says the product offers a completely new approach to dental care for companion animals and is expected to prove particularly effective in treating cats which do not respond well to existing treatments, such as dental chews and tooth-brushing.
Dentagen Aqua is a palatable liquid which is added to a pet's drinking water on a daily basis. Its active principal is RF2, a plant extract. According to the company, RF2's ability to enable natural and healthy mouth bacteria to flourish while inhibiting the formation of plaque even at low concentrations has been demonstrated in extensive clinical trials. It operates as an 'anti-biofilm' treatment, modifying the growth of the membrane of oral bacteria to prevent them from producing plaque.
Dentagen Aqua is supplied in a 250 ml bottle costing £6.80. At the recommended dose of 5 ml per day, the bottle will provide 50 days' treatment for a cat or small dog.
In 2008, Genitrix launched the original Dentagen plaque protection system which consists of a unique RF2-impregnated wax provided to practices in a syringe to be applied to the gingival layer and the buccal area of teeth of dogs or cats at end of dental procedures. Dog owners can then maintain the protective coating by giving their pet Dentagen plaque prevention chews. The launch of Dentagen Aqua means that an equivalent solution is now available for cat owners or for dogs which don't eat chews.
With over 85% of dogs and cats over three years old suffering from some form of dental or gum disease, it's the most common health problem in these animals. The market for preventative dental healthcare supplements is estimated to be close to £1 million per annum.
Rob Watkins, Marketing Director at Genitrix, said: "Dentagen exceeded our expectations during its first year and has proved popular with both vets and dog owners. Given the vital importance of good dental health for dogs and cats, it seemed the logical next step to produce a water additive version to make the treatment easier for cat owners in particular."
The RCVS is seeking feedback on a new draft Code of Professional Conduct.
The new Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Surgeons, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.
According to the College, the purpose of the review, which last took place over a decade ago, is to ensure guidance to the profession and the public is clear. For example, using consistent language to distinguish between what must be done and what is advised.
The RCVS says the new Code is a short, principles-based document using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance. It also includes:
Clare Tapsfield-Wright, Chairman of the Guides Review Working Party said: "Over the decade or so since it was last reviewed, not only has the Guide become unwieldy in places, but the way that regulators in general publish professional conduct rules has changed. Our draft new Code aims to clarify matters and bring us into line with best practice elsewhere.
"Animal owners are increasingly keen to understand the basis of what the veterinary profession considers to be good professional conduct. The new simplified Code should assist with this understanding."
The new Code, together with the consultation paper, can be downloaded at http://www.rcvs.org.uk/codeconsultation
Comments, which are welcomed from the profession and the public, should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 24 June 2011.
A separate document is under development for veterinary nurses, which will share broadly similar underlying principles and will be the subject of its own consultation.
Merial Animal Health has launched Locatim, an oral antibody supplement to aid calf scour management.
Manufactured from the colostrum of high health status cows that are hyper-immunised against E.coli, rotavirus and coronavirus, Locatim contains a guaranteed concentration of specific antibodies to enterotoxic E.coli F5 (K99).
Merial says that when given alongside the dam’s colostrum, Locatim provides enhanced protection against infection, reducing calf mortality due to neonatal diarrhoea caused by E.coli F5 (K99), and helping to protect calf health during the critical rearing period.
According to the company, a single 60ml oral dose provides direct transfer of these specific antibodies, giving local protection within the digestive tract and systemic protection following absorption through the intestinal mucosa.
For optimal absorption Locatim should be administered during the first four hours of life, but it can be given up to 12 hours after birth.
Locatim can be administered to every calf born during an outbreak of scour; at times of peak calving, when environmental challenge is high; or it can be used to enhance protection in individual calves identified as being at high risk of disease due to factors such as dystocia, weakness or the poor quality of the dam’s colostrum.
For information on purchasing stock contact your local Merial Animal Health territory manager.
The proposed framework has grown out of the VN Futures research project, run jointly with the BVNA, which identified developing a structured and rewarding career path for veterinary nurses as one of the key demands of the profession.
It has been developed by the VN Futures Post-Registration Development Group in conjunction with the RCVS Veterinary Nurses Education Committee and Veterinary Nurses Council.
The College says the proposed framework is designed to provide accessible, flexible and professionally relevant post-registration awards for veterinary nurses in order to provide an enhanced level of veterinary nursing practice, while also providing specific modules that veterinary nurses at all career levels can study independently for their continuing professional development (CPD).
Julie Dugmore, Director of Veterinary Nursing at the RCVS, said: "One of the strongest messages that came out of the research we conducted with the British Veterinary Nursing Association prior to the publication of the VN Futures Report was that there was a need for a more structured and rewarding career path for veterinary nurses.
"Throughout the VN Futures roadshow events nurses felt they were often entering a career cul-de-sac after a certain amount of time in practice and so the need for further post-registration qualifications which promote excellence and recognise advanced knowledge, skills, competency and experience in designated areas were strongly expressed.
"We have taken this feedback and developed it into a comprehensive framework for two defined post-registration qualifications and are very interested in hearing what both veterinary nurses and veterinary surgeons have to say about all aspects of what we are proposing.
"Once we have collated the responses, we will incorporate the feedback into the framework for further consideration by the relevant committees and VN Council. The eventual aim is that these qualifications will, once sufficiently bedded in, lead to the development of an Advanced Veterinary Nurse status so that members of the VN profession with the sufficient skills and experience will get the recognition they truly deserve."
The two new qualifications included in the framework are a Graduate Certificate in Advanced Veterinary Nursing and a Postgraduate Certificate in Advanced Veterinary Nursing. Details of the courses’ structure, candidate assessment criteria, accreditation standards, student support, candidate eligibility rules, the RCVS enrolment process and the procedures for certification will be set out in a framework document as part of the consultation process.
The document also includes a prospective list of designations for the two courses covering areas of advanced veterinary nursing knowledge such as wellness and preventative health; rehabilitation and physiotherapy; anaesthesia and analgesia; triage, critical care and emergency nursing; pharmacology; animal welfare; education and teaching; management and leadership; research; and, dentistry.
The consultation will be launched in early July with an email sent to all veterinary nurses and veterinary surgeons containing a link to the survey and asking for their views on the proposals. Details of the consultation, once launched, may also be found at www.rcvs.org.uk/consultations
The VN Futures Report is available to download from www.vetfutures.org.uk/vnfutures
The MSD Animal Health Research Bursary for Veterinary Surgeons offers three awards, consisting of two ruminant bursaries and one companion animal bursary, of up to £4,000 each.
Each project should be completed within one to two years and the vet practitioner proposals will be judged by university academics to ensure independent assessment.
The companion animal research bursary will be assessed by the University of Nottingham Centre for Evidence-based Veterinary Medicine and the ruminant research bursary applications will be assessed by academic staff from the University of Bristol School of Veterinary Science.
Michelle Townley, veterinary advisor at MSD Animal Health (pictured right) said: "Our Vet Surgeon Research Bursaries have an important role to play in encouraging vet surgeons to continue to develop their research skills. New knowledge and good research skills form the life-blood of the industry so we’re keen to see proposals from both ruminant and companion animal practitioners. Being awarded a bursary has proved to be a career-changing experience for some participants so we’re keen to get as many applications as possible as part of our investment in the veterinary industry."
The deadline for entries is 30th November 2018. For more information, visit www.msdahresearchbursary.co.uk.
Pet Anxiety Month aims to educate pet owners about the signs of anxiety in cats and dogs, help them identify the causes, and encourage them to take steps to support anxious pets (presumably by putting multiple diffusers in every home and blanketing large swathes of suburbia in a pea soup fog of pheromones).
Joking aside, the initiative comes on the back of the PDSA Animal Wellbeing report1 which revealed that over half of veterinary professionals think they've seen an increase in dog behavioural issues in the last two years, with over three-quarters of dog owners saying that they would like to change at least one behaviour displayed by their dog and nearly 90% of owners reporting that their cat is afraid of at least one thing.
To support the initiative, Ceva will be running a TV advertising campaign from 7 March until 21 April, which directly targets dog lovers during More4’s Crufts’ programmes (from 7 to 10 March).
The advertisements will also air on Channel 4, Channel 4 partner channels, Sky and Sky partner channels. Both advertisements are 30 seconds long.
Ceva is producing a marketing pack to raise awareness of Pet Anxiety Month containing eye-catching display materials and a social media toolkit.
Abigail King, Ceva's senior behaviour product manager, said: "More and more people are identifying anxiety and behavioural issues in their pets. Pet Anxiety Month will highlight signs of anxiety in cats and dogs that perhaps an owner is unaware of, help identify the problem and encourage changes both in and out of the home to make the household a happier place."
For further information, visit www.petanxiety.co.uk or Pet Anxiety Month on Instagram or Facebook.
Norbrook Laboratories has launched Norfenicol Solution for Injection (florfenicol), a broad spectrum antibiotic licensed for the treatment of pneumonia in cattle and pigs.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "With many farmers preparing for winter housing, the launch of Norfenicol is timely as pneumonia represents the most common disease of housed cattle in the UK costing the agricultural industry an estimated £80m per year. Norfenicol is an easy to inject, cost effective treatment of pneumonia which kills bacteria quickly, and is available in a durable plastic bottle. Studies have shown florfenicol, the active ingredient in Norfenicol, to have a high bacteriological and clinical efficacy (100% and 96% respectively) against susceptible bacteria in the treatment of calf respiratory tract diseases."
Norfenicol is indicated for the treatment of bacterial respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somniand for the treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae, and Pasteurella multocida in swine.
Dr McInerney added: "NSAIDs have also been shown to be a beneficial ancillary therapy in treating bacterial pneumonia, to alleviate pain as well as to reduce inflammation and pyrexia. Norbrook has a range of NSAID products which are available as an adjunctive treatment for pneumonia in cattle, including Loxicom 20 mg/ml solution for injection for cattle, pigs and horses."
For further product information, visit www.norbrook.com
Developed by Italian tech company, Otech Industry srl, the Onemytis 2 uniquely uses gas ionisation to vaporise tissue at lower temperatures and, claims Excel, with greater precision than is possible with conventional electrosurgery.
The knife works by a strong electromagnetic field through air. This releases plasma which vaporises tissue at a maximum operating temperature of 50°C (compared to more than 118°C in conventional electrosurgery).
During surgery, the electrode does not touch the patient. Plasma is formed when it is between 1 and 2 mm away from the patient, depending on the power setting. This means the surgeon does not apply any pressure when creating an incision, allowing greater precision.
The Onemytis range starts from £4500 +VAT.
West Sussex first opinion vet, Julian Hoad, Head of Crossways Veterinary Group, started using Onemytis last year for a range or procedures including laparoscopic surgery and the removal of masses, often without the need for a general anaesthetic.
Julian said: "I’ve used electrosurgery for 20 years and this is an order of magnitude better. It is more precise, more reliable and results in a much better healing surface."
"I recently removed an enlarged lymph node. The mass was around the mesenteric root. Because Onemytis is so precise I was able to dissect around the blood vessels, removing tissue that was attached to them with no blood loss. Onemytis is also excellent for removing epulides. It cuts though gingival tissue with very limited burning and produces very good, pain-free healing."
"I now routinely use it for performing nostril widening surgery in brachycephalic dogs; it reduces surgery time dramatically and completely abolishes bleeding in most cases."
"I have also used it to remove a large mass from a dog’s spleen and, by using a combination of Onemytis and Ligasure, managed to do so with a total blood loss of less than 2 ml."
Steve Hayden, Director at Excel Lasers, said: “We are delighted to be bringing Onemytis 2 to the UK. An important part of our role is to identify the technological innovations we think are most likely to help vets and their patients and Onemytis really stands out. The feedback we have had from our clients has been extremely positive and we think it has a fantastic future in veterinary surgery.”
To find out more about Onemytis 2 and watch videos of it in action, visit: https://www.excellasers.com/airplasma/
MMI seeks to address mental health and wellbeing issues within the veterinary profession, while the Doctors’ Support Network provides peer support for doctors and medical students with mental health concerns.
&me was launched this time last year at the Palace of Westminster at an event sponsored by Kevan Jones MP (Labour, North Durham,) who has spoken about his own experiences with depression.
Overall eleven &me ambassadors have volunteered their own stories with mental ill-health:
A number of &me ambassadors will be taking part in an ‘&me live’ session at BSAVA Congress, from 5-8 April 2018 in Birmingham, providing a short overview of their story before taking questions from the audience. The session will take place from 8.30 to 10.10am on Saturday 7 April and will be open to all those attending Congress.
Lizzie Lockett, RCVS CEO and Mind Matters Director, said: "The feedback our &me ambassadors have received is truly heartening.
"Steve Carter, for example, had both an ex-student and colleague comment on his story thanking him for all he’s done, while a Facebook post about Rob Pettitt reached nearly 25,000 people.
"The campaign highlights how it is possible to recover from mental ill-health and flourish in your career, with the aim of encouraging those at the start of their mental ill-health experience to seek appropriate help, whether that is something profession-specific, such as Vetlife or DSN, or their GP."
Louise Freeman, Co-Chair of the DSN, added: "Many healthcare professionals face similar pressures that can lead to mental ill-health, including long hours, intense pressure, and the nature of the job which requires practitioners to constantly provide care for others, without necessarily recognising the need for self-care at the same time.
"A recurring theme that we’ve seen from these ambassadors’ stories has been that they drew on support from friends and family, and we really hope that this campaign encourages other professionals to seek help if they feel they are struggling."
The campaign is interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill-health.
To participate in the campaign, email Dr Louise Freeman on vicechair@dsn.org.uk.
Further information about the ‘&me’ campaign can be found at www.vetmindmatters.org/&me, and a blog by Louise, 'Me and #AndMe', can be found at www.vetmindmatters.org/me-and-andme/.
ECM of France, a specialist in veterinary ultrasound solutions, has launched VIRTUAL SCAN - an ultrasound scanner for pig farmers and veterinarians. ECM says the scanner offers an alternative to screenless A-Mode Doppler devices, cheaper ultrasound devices, which are often poor quality.
VIRTUAL SCAN weighs 450 grams. It is equipped with an internal five-hour battery and a 5MHz sector probe. ECM says the instrument is extremely easy to handle - all the user needs to do is switch it on and the hand-held instrument is instantly ready to perform an ultrasound on sows.
VIRTUAL SCAN is a compact device (11cm x 18.5cm x 4.5cm) and does not require an external cable. According to the company, it can be used in any livestock facility, even inside narrow, hard-to-reach stalls. The screen is positioned in such a way that the image is always visible.
Using ECM's scanner, pregnancy tests can be performed as early as 21 days after insemination, so it is possible to re-inseminate any unfertilised sow without wasting a costly additional cycle. The image is easy to interpret. After use, the VIRTUAL SCAN ultrasound instrument is easy to clean with a damp cloth or water.
ECM, which is headquartered in Angoulême (in south-western France), develops and manufactures specialist veterinary-science devices. The company also provides training in ultrasound techniques, the correct way to move the probe and how to interpret the ultrasound image.
For more information, please contact:
Simon QuarmbyHOLMEFIELD Farm ServiceAgriculture HouseMurton LaneMurtonYorkT019 5UF
tel : (44) 1904 481.490fax : (44) 1904 481.211email : simon@hfsvets.com
Or visit: http://www.agroscan.com/ and http://www.ecmscan.com/
The committee heard five charges against Dr Davies at a resumed hearing of an inquiry which was originally adjourned in January and then July 2018. The decision was made, at both the 2018 hearings, to postpone the final decision on the sanction.
The first two charges against Dr Davies related to convictions for drink driving in March 2014 and October 2015 for which she received driving bans of 17 and 45 months.
The third charge related to her breaching a number of undertakings she had entered into as part of the College’s Health Protocol, including her consuming alcohol on four occasions between May 2015 and January 2016 and missing a pre-arranged appointment with a consultant psychiatrist appointed.
The fourth and fifth charges related to being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016 which was also in breach of her undertakings under the Health Protocol.
At Dr Davies' first Disciplinary Committee hearing in January 2018, she admitted all five charges against her and also accepted that her conduct was disgraceful conduct in a professional respect.
The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
At the conclusion of its hearing on 23 January 2018 the Committee decided to postpone its decision regarding sanction for six months on the basis of Dr Davies’ entering into undertakings, including not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement and to undergo blood and hair tests for alcohol consumption every two months.
At the resumed hearing on 30 July 2018, Dr Davies’ Counsel submitted on her behalf that she wished to return to practise and the Committee reviewed evidence that she provided to demonstrate she had complied with her undertakings.
However, the Committee retained concerns about Dr Davies' return to practise and therefore required her to identify a veterinary surgeon who would agree to act as her mentor, noting that the mentor would have to be acceptable to the College as someone suitable to act in that capacity.
The Committee also required the continuation of the requirements for abstinence from alcohol and the programme of blood and hair testing.
A further requirement of the Committee was that Dr Davies should make a disclosure to any new employer of her appearances before the Committee in January 2018 and in July 2018 and of the decisions it made.
The final requirement of the Committee was that the respondent should not accept a ‘sole charge position’ at any time during her employment during this next period of postponement of sanction. The Committee then directed that the hearing be postponed for a further 12 months.
The Disciplinary Committee resumed its inquiry on 7th August 2019, when Dr Davies submitted documentary proof and medical records to demonstrate she had complied with all her undertakings given at the last hearing. The Committee also heard from Dr Davies’ appointed veterinary mentor who provided a statement that concluded that she no longer needed monitoring or supervision.
The Committee then considered what sanction to impose on Dr Davies.
Ian Green, chairing the Committee and speaking on its behalf, said: "The view of the Committee is that the respondent has to date overcome her addiction to alcohol and, given that her competence as a practising veterinary surgeon is not disputed, that she should therefore be permitted to return to her chosen profession. However, in the judgment of this Committee the seriousness of the offences to which the Respondent has pleaded guilty means that a sanction of “No Further Action” cannot be justified."
The Committee therefore decided that the most proportionate sanction was for Dr Davies to be reprimanded as to the conduct she admitted at previous hearings and that she be warned as to her future conduct.
Ian added: "The respondent must understand that she has been given an opportunity to prove that, for the remainder of her time in practice, she can meet the high standards expected of all registered veterinary surgeons from both other practitioners and from members of the public who entrust the care and treatment of their animals to members of this profession."